ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/09/07 | 3,905 | 3,935 | 3,860 | 3,875 | +25 | +0.6% | 103,100 |
2021/09/06 | 3,885 | 3,885 | 3,825 | 3,850 | -30 | -0.8% | 78,200 |
2021/09/03 | 3,840 | 3,890 | 3,815 | 3,880 | +60 | +1.6% | 124,200 |
2021/09/02 | 3,810 | 3,840 | 3,785 | 3,820 | +10 | +0.3% | 94,500 |
2021/09/01 | 3,775 | 3,835 | 3,755 | 3,810 | +25 | +0.7% | 87,700 |
2021/08/31 | 3,790 | 3,810 | 3,755 | 3,785 | -5 | -0.1% | 147,700 |
2021/08/30 | 3,715 | 3,790 | 3,715 | 3,790 | +75 | +2% | 94,800 |
2021/08/27 | 3,700 | 3,755 | 3,685 | 3,715 | -25 | -0.7% | 75,700 |
2021/08/26 | 3,705 | 3,765 | 3,700 | 3,740 | +15 | +0.4% | 86,600 |
2021/08/25 | 3,700 | 3,735 | 3,665 | 3,725 | -5 | -0.1% | 92,300 |
2021/08/24 | 3,720 | 3,755 | 3,715 | 3,730 | -45 | -1.2% | 79,000 |
2021/08/23 | 3,800 | 3,845 | 3,745 | 3,775 | +15 | +0.4% | 149,600 |
2021/08/20 | 3,710 | 3,775 | 3,710 | 3,760 | +60 | +1.6% | 122,300 |
2021/08/19 | 3,660 | 3,715 | 3,660 | 3,700 | +30 | +0.8% | 100,900 |
2021/08/18 | 3,670 | 3,685 | 3,640 | 3,670 | +10 | +0.3% | 113,700 |
2021/08/17 | 3,670 | 3,700 | 3,655 | 3,660 | +20 | +0.5% | 90,400 |
2021/08/16 | 3,575 | 3,640 | 3,575 | 3,640 | +25 | +0.7% | 100,400 |
2021/08/13 | 3,585 | 3,620 | 3,580 | 3,615 | +10 | +0.3% | 61,800 |
2021/08/12 | 3,630 | 3,635 | 3,595 | 3,605 | +20 | +0.6% | 79,500 |
2021/08/11 | 3,535 | 3,605 | 3,530 | 3,585 | +80 | +2.3% | 92,700 |
2021/08/10 | 3,520 | 3,585 | 3,485 | 3,505 | -35 | -1% | 143,100 |
2021/08/06 | 3,565 | 3,585 | 3,525 | 3,540 | +50 | +1.4% | 180,600 |
2021/08/05 | 3,480 | 3,505 | 3,480 | 3,490 | -15 | -0.4% | 89,600 |
2021/08/04 | 3,510 | 3,525 | 3,485 | 3,505 | +15 | +0.4% | 87,300 |
2021/08/03 | 3,475 | 3,500 | 3,465 | 3,490 | -15 | -0.4% | 78,800 |
2021/08/02 | 3,495 | 3,525 | 3,490 | 3,505 | +60 | +1.7% | 160,600 |
2021/07/30 | 3,485 | 3,500 | 3,445 | 3,445 | -55 | -1.6% | 195,100 |
2021/07/29 | 3,485 | 3,500 | 3,475 | 3,500 | +15 | +0.4% | 97,300 |
2021/07/28 | 3,465 | 3,495 | 3,450 | 3,485 | -15 | -0.4% | 76,300 |
2021/07/27 | 3,520 | 3,525 | 3,480 | 3,500 | +5 | +0.1% | 87,000 |
2021/07/26 | 3,525 | 3,525 | 3,470 | 3,495 | +55 | +1.6% | 85,900 |
2021/07/21 | 3,410 | 3,460 | 3,390 | 3,440 | +55 | +1.6% | 158,800 |
2021/07/20 | 3,375 | 3,400 | 3,365 | 3,385 | -20 | -0.6% | 74,200 |
2021/07/19 | 3,395 | 3,420 | 3,375 | 3,405 | -40 | -1.2% | 114,400 |
2021/07/16 | 3,475 | 3,485 | 3,445 | 3,445 | -30 | -0.9% | 79,000 |
2021/07/15 | 3,530 | 3,535 | 3,475 | 3,475 | -95 | -2.7% | 109,700 |
2021/07/14 | 3,465 | 3,580 | 3,460 | 3,570 | +80 | +2.3% | 108,900 |
2021/07/13 | 3,515 | 3,525 | 3,490 | 3,490 | +20 | +0.6% | 93,200 |
2021/07/12 | 3,430 | 3,495 | 3,415 | 3,470 | +110 | +3.3% | 132,100 |
2021/07/09 | 3,315 | 3,370 | 3,285 | 3,360 | -25 | -0.7% | 194,400 |
2021/07/08 | 3,370 | 3,415 | 3,370 | 3,385 | -10 | -0.3% | 168,000 |
2021/07/07 | 3,380 | 3,415 | 3,360 | 3,395 | -50 | -1.5% | 105,500 |
2021/07/06 | 3,475 | 3,475 | 3,440 | 3,445 | ±0 | ±0% | 67,000 |
2021/07/05 | 3,465 | 3,495 | 3,440 | 3,445 | -55 | -1.6% | 79,700 |
2021/07/02 | 3,530 | 3,545 | 3,495 | 3,500 | ±0 | ±0% | 120,200 |
2021/07/01 | 3,495 | 3,515 | 3,475 | 3,500 | +5 | +0.1% | 82,400 |
2021/06/30 | 3,560 | 3,580 | 3,490 | 3,495 | -5 | -0.1% | 171,900 |
2021/06/29 | 3,515 | 3,530 | 3,490 | 3,500 | -80 | -2.2% | 151,200 |
2021/06/28 | 3,580 | 3,590 | 3,555 | 3,580 | +15 | +0.4% | 98,300 |
2021/06/25 | 3,580 | 3,590 | 3,555 | 3,565 | ±0 | ±0% | 89,900 |
951~
1000
件表示中 / 3749件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 366,000円 | +3.8% | -19.9% | 3.72% | 11.89倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
住友ファーマ | 114,600円 | -11.0% | +206.6% | 0.00% | 11.38倍 | 2.69倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
久光薬 | 398,200円 | +5.8% | +1.2% | 3.01% | 12.89倍 | 1.03倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
日本新薬 | 319,900円 | +8.0% | -15.3% | 3.88% | 8.98倍 | 0.87倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 194,200円 | +5.9% | +684.6% | 2.83% | 12.89倍 | 1.29倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム